RHYTHM PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $246.3M | $49.5M |
| FY2019 | — | $281.0M | $62.3M |
| FY2020 | — | $166.5M | $100.9M |
| FY2021 | — | $284.2M | $59.2M |
| FY2022 | — | $264.3M | $127.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $246.3M | $49.5M |
| FY2019 | — | $281.0M | $62.3M |
| FY2020 | — | $166.5M | $100.9M |
| FY2021 | — | $284.2M | $59.2M |
| FY2022 | — | $264.3M | $127.7M |